← FDA DRUG APPROVALS

FDA ANDA · ANDA077910

BISOPROLOL FUMARATE

Sponsor: AUROBINDO PHARMA

APPLICATION
ANDA077910
TYPE
ANDA
ORIGINAL APPROVAL
2006-12-27
LATEST ACTION
2011-08-29
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Prescription

Products

BISOPROLOL FUMARATEPrescription
BISOPROLOL FUMARATE 5MG · TABLET · ORAL
BISOPROLOL FUMARATEPrescription
BISOPROLOL FUMARATE 10MG · TABLET · ORAL

Approval history

2011-08-29Labeling · Supplement 5AP
2007-12-13Labeling · Supplement 1AP
2006-12-27OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →